Updates in the Treatment of Secondary AML After the 2024 SOHO Annual Meeting - Episode 4

Dose Intensity and Sequencing of Intensive Chemotherapy in Secondary AML

,

James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.